Primus In News
Union Budget 2026: Which 17 cancer drugs are now exempt from customs duty? Check list
01-02-2026
Sunita Mohanty, managing director, Primus Partners, shared her view that India’s rising burden of non-communicable diseases such as diabetes, cancer, and autoimmune disorders should serve as a wake-up call for the private sector. She noted that the Union Budget’s focus on NCDs sends a strong signal to FMCG, food, beverage, and pharmaceutical companies to go beyond compliance and actively partner in public health through clear front-of-pack labelling, healthier product reformulations, and more responsible business practices.
Explore Related Insights
- Incentives for R&D: New foreign trade policy to retain key schemes despite WTO trouble
- How civil servants are leading India’s fight against Covid-19
- MSMEs should adopt structured hiring, institutionalise background checks to minimise legal risks: Credentia CEO | Report
- Delhi plans incentives for hybrid cars, drives domestic carmakers into panic
